- Report
- March 2025
- 193 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Book
- October 2019
- 632 Pages
- Book
- January 2016
- 368 Pages
- Book
- March 2010
- 512 Pages
- Book
- December 2020
Global
Mesothelioma is a rare form of cancer that affects the mesothelial cells of the body, most commonly the lungs and abdomen. It is caused by exposure to asbestos, a mineral fiber used in many industries. Treatment for mesothelioma is typically multimodal, involving surgery, chemotherapy, and radiation.
Mesothelioma is a relatively small market within the larger oncology space. It is estimated that there are approximately 3,000 new cases of mesothelioma diagnosed in the United States each year. Despite its small size, the mesothelioma market is highly competitive, with a number of companies offering treatments and services.
Some of the companies in the mesothelioma market include Bristol-Myers Squibb, Merck, Novartis, Pfizer, and Roche. Additionally, there are a number of smaller companies that specialize in mesothelioma treatments, such as ImmunoCellular Therapeutics, OncoGenex Pharmaceuticals, and ZymoGenetics. Show Less Read more